Mar 31, 2026 06:59AM
Mar 31, 2026 06:59AM
Feb 24, 2026 07:05AM
Jan 12, 2026 07:00AM
Dec 3, 2025 05:05PM
Dec 3, 2025 05:05PM
Oct 30, 2025 07:05AM Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
Oct 20, 2025 07:00AM
Jul 31, 2025 07:05AM
Jul 29, 2025 07:07AM
Jul 28, 2025 07:19PM
May 7, 2025 07:00AM
Feb 28, 2025 07:05AM
Jan 13, 2025 09:07AM Apellis Pharmaceuticals (APLS) Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan Healthcare Conference
Jan 13, 2025 09:00AM
Nov 5, 2024 07:05AM
Aug 1, 2024 07:05AM
May 7, 2024 07:05AM
Feb 27, 2024 07:05AM
Jan 8, 2024 09:03AM
Jan 8, 2024 09:00AM Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues
Dec 11, 2023 07:04AM
Dec 11, 2023 07:00AM
Nov 1, 2023 07:05AM
Oct 2, 2023 07:00AM
Jul 31, 2023 07:00AM
May 4, 2023 04:05PM
Feb 21, 2023 04:13PM Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 21, 2023 04:13PM
Nov 18, 2022 12:25PM
Nov 18, 2022 07:01AM
Nov 18, 2022 07:00AM
Nov 18, 2022 07:00AM
Nov 7, 2022 04:05PM
Nov 7, 2022 04:05PM Apellis Pharmaceuticals Reports Third Quarter 2022 Financial Results
Nov 3, 2022 09:05AM
Nov 3, 2022 09:05AM
Aug 9, 2022 04:01AM
Aug 9, 2022 04:00AM
Aug 8, 2022 04:05PM
Aug 8, 2022 04:05PM
Jul 19, 2022 07:04AM Apellis Pharmaceuticals (APLS) Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy
Jul 19, 2022 07:00AM
Jul 19, 2022 07:00AM
Jun 10, 2022 05:34AM
Jun 10, 2022 03:00AM
Jun 10, 2022 03:00AM
May 12, 2022 11:05AM
May 12, 2022 11:05AM Apellis Announces Seven Abstracts in PNH to be Presented at the European Hematology Association Congress
May 5, 2022 06:49AM

15,627 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All